Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
Author:
Affiliation:
1. Profil Mainz Mainz Germany
2. Johannes Gutenberg University Mainz Germany
3. The Ohio State University Columbus OH USA
4. LMC Diabetes & Endocrinology Thornhill Ontario Canada
5. Janssen Research & Development, LLC Raritan NJ USA
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12273
Reference27 articles.
1. Standards of Medical Care in Diabetes—2013
2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
3. Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
4. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
5. Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea
Cited by 213 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Canagliflozin + metformin ER for the treatment of type 2 diabetes: the evidence to date;Expert Opinion on Pharmacotherapy;2023-11-02
2. Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis;Acta Diabetologica;2023-06-15
3. Aspects of the safety of hypoglycemic drugs according to the results of clinical trials;Patient-Oriented Medicine and Pharmacy;2023-06-07
4. Effect of sodium-glucose co-transporter 2 inhibitors on plasma potassium: A meta-analysis;Diabetes Research and Clinical Practice;2023-02
5. Mechanism of canagliflozin-induced vasodilation in resistance mesenteric arteries and the regulation of systemic blood pressure;Journal of Pharmacological Sciences;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3